Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II

Background Nonvitamin K oral anticoagulants require dose adjustment based on kidney function.The most common estimate of kidney function employed in clinical practice is estimated glomerular filtration rate (eGFR); however, product monographs recommend the use of the Cockcroft-Gault estimated creati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Heart Association Jg. 12; H. 6; S. e026605
Hauptverfasser:	Yao, Ren Jie Robert, Holmes, DaJuanicia N., Andrade, Jason G., Levin, Adeera, Piccini, Jonathan P., Fordyce, Christopher B.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley and Sons Inc 21.03.2023 Wiley
Schlagworte:	Administration, Oral Anticoagulants - therapeutic use atrial fibrillation Atrial Fibrillation - complications Atrial Fibrillation - diagnosis Atrial Fibrillation - drug therapy Dabigatran Humans nonvitamin K oral anticoagulant ORBIT‐AF II Original Research renal dose adjustment Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - epidemiology Rivaroxaban Stroke - diagnosis Stroke - epidemiology Stroke - etiology ORBIT‐AF II atrial fibrillation nonvitamin K oral anticoagulant renal dose adjustment
ISSN:	2047-9980, 2047-9980
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!